| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 09/19/2022 | 54.44% | Piper Sandler | $2.5 → $4 | Maintains | Neutral |
| 08/10/2022 | -22.78% | Roth Capital | → $2 | Downgrades | Buy → Neutral |
| 06/24/2022 | — | JP Morgan | Initiates Coverage On | → Neutral | |
| 05/25/2022 | -3.47% | Piper Sandler | → $2.5 | Initiates Coverage On | → Neutral |
| 08/06/2021 | 749.42% | Roth Capital | $25 → $22 | Maintains | Buy |
| 08/06/2021 | 903.86% | Oppenheimer | $25 → $26 | Maintains | Outperform |
| 08/06/2021 | 1058.3% | HC Wainwright & Co. | $35 → $30 | Maintains | Buy |
| 06/01/2021 | 672.2% | HSBC | → $20 | Initiates Coverage On | → Buy |
| 03/03/2021 | 1174.13% | Roth Capital | $20 → $33 | Maintains | Buy |
| 03/03/2021 | 1251.35% | HC Wainwright & Co. | $11 → $35 | Maintains | Buy |
| 02/26/2021 | 672.2% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
| 01/06/2021 | 247.49% | Cowen & Co. | → $9 | Upgrades | Market Perform → Outperform |
| 11/25/2020 | 93.05% | Cowen & Co. | → $5 | Initiates Coverage On | → Market Perform |
| 11/25/2020 | 29.34% | Jefferies | → $3.35 | Initiates Coverage On | → Buy |
| 12/12/2019 | 208.88% | Oppenheimer | → $8 | Initiates Coverage On | → Outperform |
| 03/20/2018 | 286.1% | B. Riley Securities | $8 → $10 | Maintains | Buy |
Amyris Questions & Answers
The latest price target for Amyris (NASDAQ: AMRS) was reported by Oppenheimer on November 9, 2022. The analyst firm set a price target for $0.00 expecting AMRS to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Amyris (NASDAQ: AMRS) was provided by Oppenheimer, and Amyris downgraded their perform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amyris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amyris was filed on November 9, 2022 so you should expect the next rating to be made available sometime around November 9, 2023.
While ratings are subjective and will change, the latest Amyris (AMRS) rating was a downgraded with a price target of $0.00 to $0.00. The current price Amyris (AMRS) is trading at is $2.59, which is out of the analyst's predicted range.